UROPASS

UROPASS

UROPASS

Tamsulosin HCl

UROGENITAL » ADRENERGIC ANTAGONIST » ALPHA-1A RECEPTOR BLOCKER

INDICATION

Treatment of the sign and symptoms of Benign Prostatic Hyperplasia (BPH).

DOSAGE AND ADMINISTRATION

Uropass capsule (Tamsulosin HCl INN 0.4 mg) is recommended once daily as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately half an hour following the same meal each day. For those patients who fail to respond to the 0.4 mg dose after two to four weeks of treatment, the dose of Uropass capsules can be increased to 0.8 mg once daily. If Uropass capsule either 0.4 mg or 0.8 mg administration is discontinued or interrupted for several days, therapy should be started again with the 0.4 mg once daily dose

COMPOSITION

Capsule : Tamsulosin HCl INN 0.4 mg as modified release pellets.